Objectif The general objective of ULISENS project is focused on the development and further commercialization of an automatic early warning system able to detect and quantify Legionella species in water. The system integrates an innovative fast detection biotechnology with an automatic module able to carry out “in situ” analysis in real-time to minimise time to results. ULISENS reduces the legionellosis lethality from 12% to 2% because of TIMELY AND COST-EFFECTIVE INFORMATION to risk owners to take appropriate effective preventive measures as soon as possible. Therefore, it prevents shutdown times and costs, penalties of fines and discredit in face to their customers and the society. The benefit from each early detection using ULISENS (around 120,000€ per case) far exceeds the initial investment (20,000-60,000€). ULISENS technical specifications:- Faster response time, reducing time to result up to 99% compared to laboratory tests - ICT Early warning system to prevent users from infection risks in real time.- Lower cost, with reductions of up to 80% compared with standard laboratory tests - Direct sampling from user’s network in real-time, no technical staff needed.- Sustainable detection biotechnology without maintenance or biological waste generation.- Great reduction of penalties and the discredit of the mark by human infections.BIOTICA is a Spanish company specialized in the development of fast techniques for the microbiological detection and quantification based on the combination of recognition biomolecules, like antibodies, with advanced nanomaterials like paramagnetic particles. Up to now, they have focused on the research and development of the ULISENS system, by means of two R&D regional and national projects aimed at developing the prototype of the system and to validate in industrial facilities its performance and functionalities. The system is ready to go a step further in the development towards the future exploitation and commercialization. Champ scientifique medical and health sciencesclinical medicinepneumologyengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringcontrol systemsnatural sciencesearth and related environmental scienceshydrologysocial sciencessociologygovernancecrisis managementengineering and technologynanotechnologynano-materials Programme(s) H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) SMEInst-03-2016-2017 - Dedicated support to biotechnology SMEs closing the gap from lab to market Appel à propositions H2020-SMEInst-2016-2017 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-2-2016-2017 Régime de financement SME-2 - SME instrument phase 2 Coordinateur BIOTICA BIOQUIMICA ANALITICA SL Contribution nette de l'UE € 768 929,00 Adresse PARQUE CIENTIFICO TECNOLOGICO Y EMPRESARIAL UNIVERSIDAD JAUME I CAMPUS RIU SEC AV SOS BAYNAT ED ESP 12071 CASTELLON Espagne Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Este Comunitat Valenciana Castellón/Castelló Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 1 098 470,00
